focus -WSS

focus

author：focus 2025-09-27 12:58:39 - browse：23168

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Health tech investors get more selective as pandemic boom fades

Wikipedia

WSS

CZI to create biohub to build anti

Steward Health Care files for bankruptcy

Software glitch causes Tandem insulin pump to shutdown, FDA warns

STAT Summit: Ending the crisis of Black deaths in the U.S.

Health tech investors get more selective as pandemic boom fades

UnitedHealth, Optum discontinue NaviHealth name

hotspot

focus

Wikipedia

Supreme Court strikes down use of affirmative action

Telehealth startups turn to complex chronic diseases

The high cost of giving birth even with insurance

Making AI in medicine accessible to smaller, and rural hospitals

In Memoriam: Notable people who died in 2023

STAT Readout Newsletter: Biotech news today

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Roivant's CEO is a star, but biotech's black hole persists

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

UnitedHealth, Optum discontinue NaviHealth name

explore

Is there really a nursing shortage in the U.S.?

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Results on Novartis prostate cancer therapy could expand its use

Study: People of West African ancestry at greater risk of cardiac amyloidosis

knowledge

Wikipedia

explore

focus